1. Introduction {#sec1}
===============

Granulomatosis with polyangiitis (GPA) is characterized by a systemic necrotizing vasculitis of medium-sized and small blood vessels \[[@B1]\]. Serum PR3-ANCA has a high sensitivity and specificity for the diagnosis of active GPA (\>90%). GPA is characterized by granulomatous upper airway involvement in approximately 90% of patients and renal involvement with necrotizing and crescentic glomerulonephritis in 75% of patients \[[@B2]\]. Chronic inflammation can lead to arterial aneurysm formation, a characteristic of medium-sized vessel vasculitis but a very unusual feature of GPA. Large vessel and medium vessel aneurysms have rarely been described \[[@B1]\]. It is important to recognize aortic or other large vessel involvement owing to the high risk of rupture, dissection, and death.

Here, we report a patient with GPA diagnosed by video-associated thoracoscopic lung biopsies of bilateral lung nodules complicated by an aortic aneurysm and positive anti-PR3-ANCA. The patient underwent successful treatment with prednisolone and cyclophosphamide. The findings were compared with several published reports of large and medium vessel aneurysms in GPA.

2. Case Presentation {#sec2}
====================

A 57-year-old Japanese man was admitted to our hospital with a chief complaint of back pain and fever for one month. A computed tomography (CT) scan showed an aneurysm of the infrarenal aorta, with a diameter of 34 mm, and inflammation of the surrounding adipose tissue, nodular lesions of the bilateral lungs, and left maxillary sinusitis ([Figure 1](#fig1){ref-type="fig"}). He was referred to our hospital for further evaluation and treatment.

At the time of admission, the patient was 168 cm tall and weighed 56.6 kg. His blood pressure was 98/69 mmHg, pulse was 84 beats per minute, and body temperature was 39.6°C. Serum creatinine was 0.66 mg/mL, and urinalysis showed 1+ occult blood; urinary sediment contained 20 red blood cells per high-power field. Serum analysis showed leukocytosis (10,000/μL) and an elevated C-reactive protein level (29.5 mg/dL). The anti-PR3-ANCA level was 187 IU/mL, and the anti-MPO-ANCA level was normal. The abdominal aortic aneurysm was suspected to be infected, and we began administering antibiotics. The patient\'s general medical condition failed to improve.

The clinical findings of left maxillary sinusitis, multiple nodular lesions in the lungs, fever, and positive anti-PR3-ANCA were clinically suspicious for GPA. Video-associated thoracoscopic lung biopsy was performed. The biopsy specimens demonstrated granulation tissue with necrosis and multinucleated giant cells ([Figure 2](#fig2){ref-type="fig"}). Most infiltrating cells were neutrophils. The ratio (%) of IgG4 to total IgG-positive cells was 33%, and there were 60 IgG4+ plasma cells per HPF in the lung.

The patient was diagnosed with GPA. He was treated with an intravenous semipulse dose of methylprednisolone, followed by oral prednisolone 1 mg/kg (55 mg) per day and intravenous administration of cyclophosphamide (700 mg/body once per month). All of the patient\'s symptoms and CT findings rapidly improved ([Figure 1(d)](#fig1){ref-type="fig"}), and the PR3-ANCA level promptly decreased to the normal range. The diameter of the aneurysm changed from 34 mm to 21 mm after treatment. On tapering doses of steroids, the patient is currently in remission, and the inflammation and PR3-ANCA elevation have completely resolved. There has been no disease recurrence for 4 years after initiation of therapy.

3. Discussion {#sec3}
=============

GPA is one of the ANCA-associated small vasculitides \[[@B3]\]. GPA is characterized by systemic necrotizing inflammation of small- to medium-sized blood vessels and granulomatous upper airway involvement in approximately 90% of patients; renal involvement with necrotizing and crescentic glomerulonephritis occurs in 75% of patients. Other organs including the skin, joints, heart, central nervous system, and eyes can also be affected \[[@B2]\].

Our patient developed lung nodules and abdominal aneurysm with inflammation, an unusual manifestation of GPA. Normally, aortic lesions are more frequently seen in large vessel vasculitis, such as giant cell arteritis and Takayasu\'s arteritis \[[@B4]\]. In our case, abdominal aneurysms showed findings of chronic periaortitis (CP) which were characterized by deposition of fibroinflammatory, periaortic tissue with the retroperitoneal tissue. The aortic diameter of CP is often normal at the time of diagnosis \[[@B5]\]. The differential diagnosis of CP includes abdominal aortic aneurysm, syphilitic mesoarteritis \[[@B6]\], IgG4-related disease (IgG4-RD) \[[@B7]\], Takayasu\'s arteritis \[[@B8]\], temporal arteritis \[[@B9]\], and infectious arteritis \[[@B10]\]. Takayasu\'s and temporal arteritis may lead to vascular occlusion and tissue ischemia. Syphilitic mesoarteritis and infectious arteritis were ruled out by serological findings and negative cultures, respectively. Takayasu\'s arteritis and temporal arteritis were also ruled out by the absence of vascular occlusion and tissue ischemia. We considered the possibility of a case of overlapping GPA and IgG4-RD. It was unclear whether the CP was due to vasculitis, granulomatous inflammation, or a predominant IgG4-RD-like pathology because histological samples of the aorta were not available. Danlos et al. proposed an overlap of IgG4-RD/ANCA-associated vasculitides (AVV) \[[@B11]\]. In their study, nearly half the patients met only one of the two immunohistological criteria of IgG4-RD (IgG4+/IgG+ plasma cell ratio \> 40% and \>10IgG4+ plasma cell per HPF) although tissue samples were obtained from the lesion with a typical IgG4-RD organ, and histologic patterns did not overlap in the same tissue \[[@B12]\]. Therefore, some patients that they considered to have overlap syndrome of IgG4-RD and AVV had no histological confirmation of IgG4-RD but did have suggestive manifestations and elevated serum IgG4 levels. Our patient had slightly elevated serum IgG4 (131 mg/dL) and CP. The ratio of IgG4-positive plasma cells to IgG-positive plasma cells (33%) did not meet the criteria for IgG4-RD, but the amount of IgG4-positive plasma cells per high-power field was very high. Thus, our patient was most likely to have overlap of IgG4-RD and GPA.

Arterial aneurysm is a very rare complication of GPA. A review of the literature identified 20 cases with arterial aneurysms in GPA, including aortic involvement in 10 patients ([Table 1](#tab1){ref-type="table"}) \[[@B1], [@B13]--[@B30]\]. Of the 20 total reported cases, in 9 patients the aneurysm ruptured, leading to death from hemorrhage in 5 patients. All of these patients were treated with medications such as steroids and cyclophosphamide, but medical treatment could not prevent aortic rupture, and the patients ultimately died. In the remaining 11 patients, including 7 with aneurysms of the aorta that did not rupture, disease remission was achieved with surgery in 6 patients and medication with prednisolone and cyclophosphamide in 1 patient. Rupture was prevented in all 10 patients who were treated surgically.

Patients with aortic aneurysm can be managed via medical or surgical approaches. Similarly, arterial aneurysms in patients with GPA can be managed by both approaches. Corticosteroids and cyclophosphamide are reportedly effective for the treatment of GPA with arterial aneurysms. Surgery is generally recommended when the diameter of an abdominal aortic aneurysm is \>60 mm. Endovascular aneurysm repair (EAR) is recommended when inflammatory aortic aneurysm (IAA) causes the thickness of retroperitoneum or adhesion of urinary duct. Medication is recommended in the case of infectious aneurysm \[[@B31]\]. We decided to administer corticosteroids and cyclophosphamide because the diameter of the aneurysm in our patient was 34 mm; we chose not to perform select EAR because we could not rule out the possibility of infectious aneurysm. IAA is often treated with EAR, which can reduce the risk associated with severe intraoperative cardiac and pulmonary complications \[[@B32]\]. Immunosuppressive therapies could reduce adventitial thickening; however, we needed to consider the risk of aneurysmal rupture due to thinning of the adventitia. The condition of the aneurysm should be checked by imaging frequently because it cannot be predicted when the aneurysm might rupture after treatment.

In conclusion, we present a rare case of GPA with lung nodules and abdominal aortic aneurysm. GPA should be included in the differential diagnosis of large vessel vasculitis, which can give rise life-threatening periaortic inflammation. The possibility of aneurysmal rupture should be carefully considered when administering immunosuppressive therapies for GPA with aneurysm.
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![Chest radiograph and computed tomography (CT) of our patient with granulomatosis with polyangiitis. (a) Chest radiography demonstrating lung nodules. (b) CT of the chest showing lung nodules bilaterally. (c) CT of the abdomen showing a localized abdominal aortic aneurysm with a periaortic soft tissue mass. (d) CT of the abdomen after treatment. (e) CT of the left maxillary sinus.](CRIRH2018-9682801.001){#fig1}

![Histopathological findings of lung nodules from our patient with granulomatosis with polyangiitis. (a) Hematoxylin and eosin (H&E) staining (×40) of lung biopsy showing necrosis and inflammatory cell infiltration. (b) H&E staining (×100) of lung biopsy showing vascular occlusion and multinucleated giant cells. (c) Elastica van Gieson (EVG) staining (×40) of the lung showing destruction of the arterial medium. (d) EVG staining (×100) of lung biopsy showing vascular occlusion.](CRIRH2018-9682801.002){#fig2}

###### 

Case of aortic involvement in granulomatosis with polyangiitis.

  Case            Age/gender (years)   Affected site                                Antibodies                                      Duration of complaint   Treatment                                                                    Rupture   Outcome
  --------------- -------------------- -------------------------------------------- ----------------------------------------------- ----------------------- ---------------------------------------------------------------------------- --------- ---------
  1 \[[@B1]\]     38/M                 TAA                                          Anti-neutrophil cytoplasmic antibodies × 128    NS                      Surgery (J-graft) + PSL 15 mg/day                                            Yes       Good
  2 \[[@B13]\]    51/M                 Distal part of aorta (3.8 cm)                Anti-proteinase-3 antibodies \> 530 kU/L        2 months                Steroid pulse + PSL 1 mg/kg + CY 2 mg/kg/day                                 No        Good
  3 \[[@B14]\]    45/M                 Aorta, extending to the right iliac artery   ANCA + NS                                       5 days                  Right ureterolysis + immunosuppressive therapy                               No        Good
  4 \[[@B15]\]    33/M                 AAA                                          Antiproteinase-3 (\>1/10)                       3 weeks                 IJV graft + PSL + CY                                                         No        Good
  5 \[[@B16]\]    42/M                 AAA                                          Antiproteinase-3 157 AU/l                       1 month                 Aortoiliac graft and high-dose PSL + CY 2 mg/kg/day                          No        Good
  6 \[[@B17]\]    63/M                 AAA (5.4 cm)                                 p-ANCA 1/80 and MPO 28 U/l                      2 months                Surgery + PSL 1 mg/kg + CY 2 mg/kg                                           No        Good
  7 \[[@B18]\]    50/F                 TAA                                          p-ANCA (1 : 320) antimyeloperoxidase 440 U/ml   2 months                PSL + CY                                                                     Yes       Death
  8 \[[@B19]\]    43/M                 Infrarenal aorta (3.1 × 3.5 cm)              NS                                              1 week                  PSL + surgery                                                                No        Good
  9 \[[@B20]\]    29/M                 Branches of hepatic and renal arteries       Anti-PR3 ANCA 15 IU/mL                          NS                      Coil embolization + steroid pulse + PSL 60 mg + MMF 2.5 g                    No        Good
  10 \[[@B21]\]   34/M                 Anterior choroidal artery                    PR3 ANCA 457 EU                                 1 year                  Clipping + steroid pulse + PSL 40 mg + CY                                    Yes       Good
  11 \[[@B22]\]   67/M                 Superior pancreaticoduodenal artery          C-ANCA 1 : 512 PR3 ANCA 88 IU/L                 11 months               IVCY (0.7 g/m2) every 3 weeks + steroid pulse + PSL 1 mg/kg/day              Yes       Death
  12 \[[@B23]\]   58/F                 Subclavian aneurysm                          P-ANCA 68 units                                 2 months                PSL 1 mg/kg + CY 2 mg/kg + stent graft                                       No        Good
  13 \[[@B24]\]   56/M                 Left gastric artery                          C-ANCA positive                                 1 month                 None                                                                         Yes       Death
  14 \[[@B25]\]   55/M                 Hepatic artery                               C-ANCA 1 : 80                                   3 weeks                 mPSL + CY                                                                    Yes       Death
  15 \[[@B26]\]   24/M                 Bilateral renal artery                       NS                                              6 weeks                 PSL 30 mg + CY 150 mg/day                                                    Yes       Good
  16 \[[@B27]\]   59/M                 Aorta                                        C-ANCA 158 SLI units                            9 months                Coronary artery bypass + steroid pulse + PSL + CY 3 mg/kg + plasmapheresis   No        Good
  17 \[[@B28]\]   35/M                 Hepatic, renal, splanchnic                   C-ANCA positive                                 6 weeks                 Steroid pulse + PSL + IVCY 750 mg                                            Yes       Good
  18 \[[@B29]\]   30/M                 Renal artery                                 NS                                              1 month                 PSL 1 mg/kg/day and CY 2 mg/kg/day                                           No        Good
  19 \[[@B30]\]   53/F                 Renal artery                                 NS                                              20 days                 PSL 1 mg/kg/day + CY 2 mg/kg/day + hemodialysis                              No        Good
  20 \[[@B30]\]   79/M                 TAA                                          PR3-ANCA 1180 EU                                8 months                Steroid pulse PSL 60 mg + IVCY 300 mg                                        Yes       Death
  Present case    58/M                 AAA                                          PR3 ANCA 187 IU/ml                              2 weeks                 Steroid pulse + PSL 55 mg + IVCY 500 mg                                      No        Good

TAA: thoracic aortic aneurysm; AAA: abdominal aortic aneurysm; F: female; M: male; NS: not stated; PSL: prednisolone; CY: cyclophosphamide; mPSL: methylprednisolone; MMF: mycophenolate mofetil; IVCY: intravenous cyclophosphamide; IJV: internal jugular vein.
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